Cite
MLA Citation
Sarah Davis et al.. “Low‐dose ibrutinib in the treatment of refractory pure red cell aplasia in chronic lymphocytic leukaemia.” Internal medicine journal, vol. 50, no. 8, 2020, pp. 1013–1015. http://access.bl.uk/ark:/81055/vdc_100106890545.0x000014